ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B02BD08 | BioTech | Eptacog alfa (activated) recombinant - 5mg | 5541 | 218017/09 | NOVOSEVEN RT | 5mg (250KIU) | 1 | Injectable powder for solution+diluent | IV | Mersaco | Novo Nordisk AS | Denmark | 257,452,982 L.L | 2.44 | E2 | Novo Nordisk AS | Denmark | 2/5/2024 | 0 |